Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma

Abstract Esophageal cancer (EC) occupies the seventh spot of the most prevalent malignancy cancer ailments worldwide and the sixth leading cause of cancer‐related death. Esophageal squamous cell carcinoma (ESCC) is also the most predominant histological subtype of EC, and cisplatin (DDP) is commonly...

Full description

Bibliographic Details
Main Authors:	Kewei Song, Chenhui Ma, Baohong Gu, Bofang Wang, Huanhuan Ma, Xiaobo Deng, Hao Chen
Format:	Article
Language:	English
Published:	Wiley 2023-11-01
Series:	Thoracic Cancer
Subjects:	cisplatin drug‐resistance epithelial‐mesenchymal transformation esophageal squamous cell carcinoma tumor
Online Access:	https://doi.org/10.1111/1759-7714.15094

Similar Items

Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma
by: Dongxi Hong, et al.
Published: (2018-06-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

Downregulation of long non‐coding RNA LOC101928477 correlates with tumor progression by regulating the epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
by: Demiao Kong, et al.
Published: (2021-05-01)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
by: Boli Yang, et al.
Published: (2021-08-01)

Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
by: Boli Yang, et al.
Published: (2022-03-01)

Antitumor Efficacy and Mechanisms of Lapatinib in Combination with Cisplatin on Esophageal Squamous Cancer Cells
by: DOU Qiaohua, et al.
Published: (2019-09-01)

Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells
by: Masahiro Yoshioka, et al.
Published: (2017-08-01)

Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis
by: Xinfang Yu, et al.
Published: (2017-06-01)

Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer
by: Kenji Tsuchihashi, et al.
Published: (2022-07-01)

TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma
by: Sima Ardalan Khales, et al.
Published: (2022-12-01)

Effect of LncRNA PTENP1 on TGF-β-induced Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma
by: FU Shenbo, et al.
Published: (2023-09-01)

RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes
by: Rui‐Jie Zeng, et al.
Published: (2019-09-01)

LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation
by: Rui Cai, et al.
Published: (2020-03-01)

Cultivation of Head and Neck Squamous Cell Carcinoma Cells with Wound Fluid Leads to Cisplatin Resistance via Epithelial-Mesenchymal Transition Induction
by: Till Jasper Meyer, et al.
Published: (2021-04-01)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
by: Milad Ashrafizadeh, et al.
Published: (2020-06-01)

A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence
by: Qi Liu, et al.
Published: (2020-04-01)

Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
by: Xin Wang, et al.
Published: (2023-03-01)

MAGE‐C3 promotes cancer metastasis by inducing epithelial‐mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma
by: Qingnan Wu, et al.
Published: (2021-12-01)

Clinical Efficacy of Anlotinib Combined with Paclitaxel and Cisplatin as First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
by: YANG Xiaoli, et al.
Published: (2021-07-01)

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
by: Wei Cui, et al.
Published: (2020-12-01)

EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway
by: Rui Zhang, et al.
Published: (2020-01-01)

Epithelial-Fibroblast Crosstalk in Eosinophilic EsophagitisSummary
by: Amanda B. Muir, et al.
Published: (2024-01-01)

Capsaicin inhibits migration and invasion via inhibiting epithelial-mesenchymal transition in esophageal squamous cell carcinoma by up-regulation of claudin-3 expression
by: Ji Feng, et al.
Published: (2022-02-01)

Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties
by: Feng-Che Kuan, et al.
Published: (2023-12-01)

CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
by: Yen-Hao Chen, et al.
Published: (2021-08-01)

PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis
by: Jia Zhao, et al.
Published: (2023-12-01)

A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma
by: Ning Li, et al.
Published: (2022-12-01)

Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
by: Hyeong Sim Choi, et al.
Published: (2021-07-01)

DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
by: Xiaosu Chen, et al.
Published: (2021-03-01)

Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma
by: Jaqueline Vaz Vanini, et al.
Published: (2022-04-01)

Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
by: Hui Li, et al.
Published: (2022-06-01)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
by: Xi-Lei Zhou, et al.
Published: (2021-05-01)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
by: Jason Chia‐Hsun Hsieh, et al.
Published: (2021-12-01)

Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
by: Li Jiang, et al.
Published: (2022-12-01)

p38 Mitogen-Activated Protein Kinase Inhibition of Mesenchymal Transdifferentiated Tumor Cells in Head and Neck Squamous Cell Carcinoma
by: Julia Federspiel, et al.
Published: (2023-12-01)

Downregulation of RBM17 enhances cisplatin sensitivity and inhibits cell invasion in human hypopharyngeal cancer cells
by: Wang Xiaolin, et al.
Published: (2023-03-01)

The Differential Metabolic Response of Oral Squamous Cell Carcinoma Cells and Normal Oral Epithelial Cells to Cisplatin Exposure
by: Xun Chen, et al.
Published: (2022-04-01)

Chaperone‐mediated autophagy affects tumor cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma
by: Dujuan Cao, et al.
Published: (2021-04-01)

Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells
by: Yuto Kubo, et al.
Published: (2022-08-01)

Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
by: Philipp Baumeister, et al.
Published: (2021-10-01)